Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Drugs & Aging

Issue 2/2000

Content (10 Articles)

Leading Article

Photodynamic Therapy in Gastrointestinal Cancer

Hugh Barr

Disease Management

Optimising Management of Patients with Advanced Heart Failure

Brigitte Stanek

Review Article

Recognition and Treatment of Dysthymia in Elderly Patients

Silvio Bellino, Filippo Bogetto, Patrizia Vaschetto, Simona Ziero, Luigi Ravizza

Review Article

Cholinesterase Inhibitors for the Treatment of Alzheimer’s Disease in the Elderly

Chad M. VanDen Berg, Yusuf Kazmi, Michael W. Jann

New Drug Profile

Verteporfin

Lesley J. Scott, Karen L. Goa

New Drug Profile

Verteporfin

Ursula Schmidt-Erfurth

New Drug Profile

Verteporfin

Carmen A. Puliafito, Adam Martidis

New Drug Profile

Extended-Release Oxybutynin

Alison M. Comer, Karen L. Goa

New Drug Profile

Extended-Release Oxybutynin

Gary E. Leach

New Drug Profile

Extended-Release Oxybutynin

Rodney U. Anderson

Jan 00
Issue: 1/2000
Mar 00
Issue: 3/2000

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits